GADICKE ANSBERT - Insider Trades & Share Buys/Sales

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for GADICKE ANSBERT

Goto 0, 1, 2, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2025-12-02 Sale	2025-12-04 6:18 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC Former 10% Owner	199,732	$0.91761	$183,275	4,784,111 (Indirect)	View
2025-11-26 Sale	2025-12-01 6:11 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	141,927	$0.96426	$136,855	4,983,843 (Indirect)	View
2025-11-21 Sale	2025-11-25 6:03 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	195,666	$0.91764	$179,551	5,125,770 (Indirect)	View
2025-11-18 Sale	2025-11-20 5:50 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	160,103	$0.92386	$147,913	5,321,436 (Indirect)	View
2025-11-13 Sale	2025-11-17 7:20 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	209,652	$0.95713	$200,665	5,481,539 (Indirect)	View
2025-11-07 Sale	2025-11-12 7:31 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	213,529	$1.13	$241,278	5,691,191 (Indirect)	View
2025-11-04 Sale	2025-11-06 7:40 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	242,890	$1.2178	$295,781	5,904,720 (Indirect)	View
2025-10-30 Sale	2025-11-03 7:07 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	295,043	$1.3274	$391,636	6,147,610 (Indirect)	View
2025-10-27 Sale	2025-10-29 7:21 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	276,017	$1.6173	$446,403	6,442,653 (Indirect)	View
2025-05-13 Sale	2025-05-15 5:34 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT MPM BioImpact LLC Oncology Impact Fund (Cayman) Management L.P. UBS Oncology Impact Fund L.P. Former 10% Owner	1,031,931	$8.06	$8,317,364	3,452,797 (Indirect)	View
2025-03-27 Sale	2025-04-30 4:08 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	4,386	$1.05	$4,605	6,718,670 (Indirect)	View
2024-12-10 Sale	2024-12-12 5:00 pm	Entrada Therapeutics Inc.	TRDA	MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner	44,722	$20.51	$917,111	4,381,062 (Indirect)	View
2023-05-22 Sale	2023-05-24 4:38 pm	TCR2 THERAPEUTICS INC.	TCRR	GADICKE ANSBERT Director 10% Owner	70,170	$1.88	$131,920	7,529,946 (Indirect)	View
2022-01-04 Sale	2022-01-06 4:12 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	245,469	$42.58	$10,452,334	4,484,728 (Indirect)	View
2021-12-03 Sale	2021-12-07 6:33 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	83,390	$33.73	$2,812,428	4,730,197 (Indirect)	View
2021-11-30 Sale	2021-12-02 6:53 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	139,773	$34.47	$4,817,417	4,813,587 (Indirect)	View
2021-11-26 Sale	2021-11-30 4:49 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	38,566	$35.18	$1,356,825	4,953,360 (Indirect)	View
2021-11-22 Sale	2021-11-24 6:38 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	129,617	$36.61	$4,744,666	5,007,597 (Indirect)	View
2021-11-02 Purchase	2021-11-04 5:37 pm	Entrada Therapeutics Inc.	TRDA	MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner	100,000	$20	$2,000,000	4,425,784 (Indirect)	View
2021-10-15 Sale	2021-10-18 4:33 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	28,615	$27.45	$785,384	5,137,214 (Indirect)	View
2021-10-12 Sale	2021-10-14 5:26 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	95,002	$27.21	$2,584,606	5,165,829 (Indirect)	View
2021-10-07 Sale	2021-10-12 4:33 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	87,006	$27.23	$2,368,800	5,260,831 (Indirect)	View
2021-10-01 Sale	2021-10-05 4:31 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	46,130	$27.05	$1,247,590	5,347,837 (Indirect)	View
2021-09-28 Sale	2021-09-30 5:05 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	35,990	$27	$971,730	5,393,967 (Indirect)	View
2021-09-23 Sale	2021-09-27 5:51 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	89,476	$27.76	$2,484,094	5,429,957 (Indirect)	View
2021-09-21 Sale	2021-09-23 4:18 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	56,779	$27.5	$1,561,394	5,519,433 (Indirect)	View
2021-09-16 Sale	2021-09-20 6:30 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	152,711	$28.38	$4,334,452	5,576,212 (Indirect)	View
2021-09-16 Sale	2021-09-20 5:30 pm	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Director 10% Owner	3,556	$29.06	$103,337	7,892,819 (Indirect Direct)	View
2021-09-14 Sale	2021-09-16 4:46 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	76,417	$27.7	$2,116,733	5,728,923 (Indirect)	View
2021-09-14 Sale	2021-09-16 4:44 pm	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Director 10% Owner	15,401	$29.17	$449,174	7,896,375 (Indirect Direct)	View
2021-09-09 Sale	2021-09-13 7:02 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	96,456	$28.32	$2,731,460	5,805,340 (Indirect)	View
2021-09-09 Sale	2021-09-13 6:22 pm	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Director 10% Owner	26,468	$29.23	$773,720	7,911,776 (Indirect Direct)	View
2021-09-07 Sale	2021-09-08 7:19 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	71,232	$29.03	$2,067,786	5,933,136 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-03-27 Exercise	2025-04-30 4:08 pm	N/A 2025-04-09	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	50,873	$0	6,718,670 (Indirect)	View
2025-03-27 Exercise	2025-04-30 4:08 pm	N/A N/A	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	50,873	$0.09	6,718,670 (Indirect)	View
2023-06-01 Other	2023-06-05 4:35 pm	N/A N/A	TCR2 THERAPEUTICS INC.	TCRR	GADICKE ANSBERT Director 10% Owner	7,529,946	$0	7,529,946 (Indirect)	View
2023-05-22 Exercise	2023-05-24 4:38 pm	N/A N/A	TCR2 THERAPEUTICS INC.	TCRR	GADICKE ANSBERT Director 10% Owner	178,269	$0.74	7,529,946 (Indirect)	View
2023-05-22 Exercise	2023-05-24 4:38 pm	2016-12-13 2026-12-12	TCR2 THERAPEUTICS INC.	TCRR	GADICKE ANSBERT Director 10% Owner	178,269	$0	7,529,946 (Indirect)	View
2021-12-21 Ownership	2023-02-10 4:26 pm	N/A N/A	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Former Director Director 10% Owner	350,938	$4.3	8,243,757 (Direct)	View
2021-12-21 Ownership	2023-02-10 4:26 pm	N/A 2030-10-28	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Former Director Director 10% Owner	350,938	$0	8,243,757 (Direct)	View
Ownership	2023-02-10 4:26 pm	N/A N/A	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Former Director Director 10% Owner	0	$0	8,243,757 (Indirect)	View
2022-07-28 Option Award	2022-08-01 4:34 pm	N/A N/A	Allovir Inc.	ALVR	GADICKE ANSBERT Director 10% Owner	3,253,796	$4.61	16,704,963 (Indirect)	View
2022-06-22 Option Award	2022-06-23 6:22 pm	N/A 2032-06-21	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Director	16,475	$0	16,475 (Direct)	View
2022-05-17 Option Award	2022-05-19 4:27 pm	N/A 2032-05-16	Allovir Inc.	ALVR	GADICKE ANSBERT Director 10% Owner	27,500	$0	27,500 (Direct)	View
2021-09-16 Option Award	2022-03-25 7:32 pm	N/A 2031-09-15	Cullinan Oncology Inc.	CGEM	GADICKE ANSBERT Director 10% Owner	7,800	$0	7,800 (Direct)	View
2021-11-17 Other	2021-11-24 6:38 pm	N/A N/A	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	15,671	$0	5,007,597 (Indirect)	View
2021-11-02 Conversion	2021-11-04 5:37 pm	N/A N/A	Entrada Therapeutics Inc.	TRDA	MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner	35,626,700	$0	4,425,784 (Indirect)	View
Ownership	2021-10-28 8:45 pm	N/A N/A	Entrada Therapeutics Inc.	TRDA	MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner	0	$0	4,325,784 (Indirect)	View
2021-09-07 Other	2021-09-08 7:19 pm	N/A N/A	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner	31,340	$0	5,933,136 (Indirect)	View

Goto 0, 1, 2, Next

GADICKE ANSBERT - Insider Trading & Ownership